Free shipping on all orders over $ 500

Vortioxetine hydrobromide

Cat. No. M2134

All AbMole products are for research use only, cannot be used for human consumption.

Vortioxetine hydrobromide Structure
Synonym:

Lu AA21004

Size Price Availability Quantity
5mg USD 35  USD35 In stock
10mg USD 50  USD50 In stock
50mg USD 100  USD100 In stock
100mg USD 140  USD140 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Vortioxetine hydrobromide is a novel multimodal antidepressant and a 5-HT transporter (5-HTT) inhibitor in vitro. Vortioxetine (Lu AA21004) inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively. Vortioxetine significantly increased cell proliferation and cell survival and stimulated maturation of immature granule cells in the subgranular zone of the dentate gyrus of the hippocampus after 21 days of treatment. Vortioxetine enhances contextual and episodic memory in rat behavioral models. Vortioxetine (Lu AA21004) displays an antidepressant and anxiolytic profile following repeated administration associated with increased neurogenesis at several stages.

Chemical Information
Molecular Weight 379.36
Formula C18H22N2S.HBr
CAS Number 960203-27-4
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Guilloux JP, et al. Neuropharmacology. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.

[2] Mahableshwarkar AR, et al. Curr Med Res Opin. A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.

[3] Bang-Andersen B, et al. J Med Chem. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.

Related 5-HT Receptor Products
Tegaserod

Tegaserod is an orally active serotonin receptor 4 (5-HT4R) agonist and a 5-HT2B receptor antagonist. Tegaserod has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. Tegaserod causes tumor cell apoptosis, blunts PI3K/Akt/mTOR signaling and decreases S6 phosphorylation.

cis-Urocanic acid

cis-Urocanic acid is a 5-HT2A receptor agonist. cis-Urocanic acid binds to 5-HT receptor with relatively high affinity (Kd=4.6 nM). cis-Urocanic acid is also an immune modulator that induces immunosuppression.

5-HT2B antagonist-1

5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC50 value of 33.4 nM.

AS19 

AS19 is a potent, selective 5-HT7 receptor agonist with an IC50 value of 0.83 nM and a Ki of 0.6 nM.

CP94253 

CP94253 is a selective, orally active agonist for serotonin receptor 1B (5-HT1B), through competitive binding with iodocyanopindolol (ICP) to the 5-HT1 receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Vortioxetine hydrobromide, Lu AA21004 supplier, 5-HT Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.